We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

CVT Shareholders Sue To Stop $1.4B Biotech Merger

Law360 (March 24, 2009, 12:00 AM EDT) -- Shareholders of CV Therapeutics have filed a proposed class action in a California state court to stop the company from carrying out a proposed $1.4 billion merger with Gilead Sciences, which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.